Author: Jan Kreusel

Spin-off of PGXperts GmbH

Fürth, May 7, 2024 – HMG Systems Engineering announces the transfer of its innovation in the field of pharmacogenetics to a new company: PGXperts GmbH. This spin-off marks an important milestone after nine years of research and development in the field of personalized medication, which was rewarded with high customer acceptance in 2023.


Partnership between Bavaria and Québec

Congratulations on the 35th anniversary of the partnership between the Free State of Bavaria and the province of Québec. This close relationship has linked art, business and science since 1989. As part of the anniversary celebrations, our Managing Director Herna Muñoz-Galeano participated in the breakfast discussion on gender equality.


PGXperts on Bavarian delegation trip to North America

PGXpert’s Product Owner Michael Hußnätter and Business Developer Martin Gröne will participate in a Digital Health delegation trip to Montréal (Canada) and Boston (USA) from October 15 to 21.

The goal of this trip is to open up new business opportunities and strengthen existing relationships. The program includes a visit to OctoberINVESfest 2023 and a Digital Health Workshop with MEDTEQ+, a renowned Canadian healthcare network of which we became a member this year.


PREPARE study: Personalised medication reduces side effects by 30%

As an innovative company in the field of personalised medication, we are pleased to share the promising results of the PREPARE study, which was conducted by the international UPGx consortium.
In the PREPARE-Studiy („PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions“), the use of a drug passport containing genotyping of 12 genes and 50 genetic variants that affect drug degradation in the body was investigated.

Erfahren Sie mehr über uns